close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DermTech, Inc. - Common Stock (NQ:DMTK)

0.0940 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about DermTech, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
DermTech Management to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
From DermTech, Inc.
Via Business Wire
News headline image
DermTech to Present at Florida Association of Health Plans 2021 Annual Conference
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Management to Participate at the Lake Street 2021 BIG5 Conference
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Reports Second Quarter 2021 Financial Results
From DermTech, Inc.
Via Business Wire
News headline image
DermTech to Announce Second Quarter Financial Results on August 4, 2021
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Announces New San Diego Headquarters
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Announces New Appointment of Monica Tellado to its Board of Directors
From DermTech, Inc.
Via Business Wire
News headline image
DermTech CEO John Dobak, M.D. Wins San Diego Business Journal CEO of the Year Award, Public Company, Medium Category
From DermTech, Inc.
Via Business Wire
News headline image
DermTech to Partner with University of Barcelona for Research Study on Atopic Dermatitis and Psoriasis
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Announces Three New Key Leadership Appointments: Chief Medical Officer, Vice President, Sales and Vice President, Information Technology and Digital Systems
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Announces Three New Scientific Advisory Board Members
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Management to Participate in Upcoming Investor Conferences
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Reports First Quarter 2021 Financial Results
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Management to Present at the UBS Global Healthcare Virtual Conference
From DermTech
Via Business Wire
News headline image
DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin Exams
From DermTech
Via Business Wire
News headline image
DermTech to Announce First Quarter Financial Results on May 13, 2021
From DermTech, Inc.
Via Business Wire
News headline image
DermTech to Collaborate on Longitudinal Study on Hidradenitis Suppurativa (HS)
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Introduces PLAplus with Improved Sensitivity for Early Detection of Melanoma
From DermTech, Inc.
Via Business Wire
News headline image
DermTech Joins Skin Cancer Foundation Corporate Council
From DermTech, Inc.
Via Business Wire
News headline image
OptumInsight Study Describes Cost Savings of DermTech’s Pigmented Lesion Assay in the Management of Melanoma
From DermTech, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today